Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 1:59:128546.
doi: 10.1016/j.bmcl.2022.128546. Epub 2022 Jan 12.

Antischistosomal tetrahydro-γ-carboline sulfonamides

Affiliations

Antischistosomal tetrahydro-γ-carboline sulfonamides

Rongguo Ren et al. Bioorg Med Chem Lett. .

Abstract

We discovered tetrahydro-γ-carboline sulfonamides as a new antischistosomal chemotype. The aryl sulfonamide and tetrahydro-γ-carboline substructures were required for high antischistosomal activity. Increasing polarity improved solubility and metabolic stability but decreased antischistosomal activity. We identified two compounds with IC50 values <5 µM against ex vivo Schistosoma mansoni.

Keywords: Antischistosomal; SAR; Sulfonamides; Tetrahydro-γ-carboline.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Witkop oxidation of 1 by ozonolysis.
Scheme 1.
Scheme 1.
Reagents and conditions: (a) O3, 4:1 DCM/MeOH, −78 °C, 10 min, then Me2S, −78 °C to rt, 2 h; (b) bromoacetamide, NaH, DMF, 0 °C to rt, 24 h;
Scheme 2.
Scheme 2.
Reagents and conditions: (a) 1-fluoro-4-isocyanatobenzene, DCM, 0 °C to rt, 24 h; (b) (4-fluorophenyl)methanesulfonyl chloride, Et3N, DCM, Ar, 0 °C to rt; 24 h; (c) 4-fluorobenzenesulfonyl chloride, Et3N, DCM, Ar, 0 °C to rt; 24 h.
Scheme 3.
Scheme 3.
Reagents and conditions: (a) Et3N (2N aq. NaOH – 63) DCM, Ar, 0 °C to rt; 24 h.
Scheme 4.
Scheme 4.
Reagents and conditions: (a) Et3N (1N aq. NaOH – 19), DCM, Ar, 0 °C to rt; 24 h; (b) morpholine, HOBT, N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDCI), Et3N dimethylacetamide, rt, 24 h; (c) 28% wt. NH4OH, rt, 12 h.

References

    1. Schistosomiasis Gryseels B.. Infect Dis Clin North Am. 2012;26:383–397. - PubMed
    1. Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet 2014;383:2253–2264. - PMC - PubMed
    1. Vale N, Gouveia MJ, Rinaldi G, Brindley PJ, Gärtner F, Correia da Costa JM. Praziquantel for schistosomiasis: Single-drug metabolism revisited, mode of action, and resistance. Antimicrob Agents Chemother. 2017;61:e02582–16. - PMC - PubMed
    1. Utzinger J, N’goran EK, Caffrey CR, Keiser J. From innovation to application: Social-ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop. 2011;120:S121–S137. - PubMed
    1. Olliaro P, Delgado-Romero P, Keiser J. The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer). J Antimicrob Chemother. 2014;69:863–870. - PubMed

Publication types

MeSH terms

LinkOut - more resources